| Mankind Pharma Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs & Formln) |
|---|
|
BSE Code:
543904
ISIN Demat:
INE634S01028
Book Value(₹): 354.72 NSE Symbol:
MANKIND
Div & Yield(%):
N.A
Market Cap(₹ Cr): 105,753.00 P/E(TTM):
58.43
EPS(TTM):
43.85
Face Value(₹): 1.00 |
| Particulars | Jun 2025 (₹ Cr) | Mar 2025 (₹ Cr) | Dec 2024 (₹ Cr) |
|---|---|---|---|
| Gross Sales | 2,541.36 | 2,126.59 | 2,414.41 |
| Excise Duty | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,541.36 | 2,126.59 | 2,414.41 |
| Other Operating Income | 0.00 | 0.00 | 0.00 |
| Other Income | 64.22 | 219.32 | 70.37 |
| Total Income | 2,605.58 | 2,345.91 | 2,484.78 |
| Total Expenditure | 1,868.29 | 1,649.67 | 1,668.31 |
| PBIDT | 737.29 | 696.24 | 816.47 |
| Interest | 146.70 | 162.25 | 200.27 |
| PBDT | 590.59 | 533.99 | 616.20 |
| Depreciation | 96.93 | 105.24 | 91.11 |
| Tax | 92.14 | 93.07 | 135.85 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -11.24 | -46.78 | -22.78 |
| Reported Profit After Tax | 412.76 | 382.46 | 412.02 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 412.76 | 382.46 | 412.02 |
| EPS (Unit Curr.) | 10.00 | 9.27 | 10.35 |
| EPS (Adj) (Unit Curr.) | 10.00 | 9.27 | 10.35 |
| Calculated EPS (Unit Curr.) | 10.00 | 9.27 | 10.29 |
| Calculated EPS (Adj) (Unit Curr.) | 10.00 | 9.27 | 10.29 |
| Calculated EPS (Ann.) (Unit Curr.) | 40.02 | 37.08 | 41.14 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 40.02 | 37.08 | 41.14 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 100.00 | 0.00 | 0.00 |
| Equity | 41.26 | 41.26 | 40.06 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 29.01 | 32.74 | 33.82 |
| PBDTM(%) | 23.24 | 25.11 | 25.52 |
| PATM(%) | 16.24 | 17.98 | 17.07 |
